An Open Single Centre Study to Evaluate the Long-term Antibody Persistence and Immune Memory Between 16 and 20 Years After the Primary Study HAB-032 (208127/022) in Which Healthy Adults Were Vaccinated With Twinrix Adult Following a Three-dose Schedule.
Phase of Trial: Phase IV
Latest Information Update: 24 Dec 2015
At a glance
- Drugs Hepatitis A-hepatitis B vaccine (Primary)
- Indications Hepatitis A; Hepatitis B
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline; GlaxoSmithKline Biologicals
- 21 Dec 2015 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 06 Mar 2015 Planned End Date changed from 1 Apr 2014 to 1 Jun 2015 as reported by ClinicalTrials.gov record.
- 06 Mar 2015 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov record.